387
Views
32
CrossRef citations to date
0
Altmetric
Review

MMR vaccination and disease elimination: the Finnish experience

, , &
Pages 1045-1053 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Wei Qin, Yao Wang, Tao Yang, Xiao-Kang Xu, Xiang-Mei Meng, Chang-Jun Zhao, Shao-Yi Li, Shao-Yu Xie, Kai-Chun Li & Hong Su. (2019) Outbreak of mumps in a student population with high vaccination coverage in China: time for two-dose vaccination. Human Vaccines & Immunotherapeutics 15:9, pages 2106-2111.
Read now
Sabine Wicker & Helena C Maltezou. (2014) Vaccine-preventable diseases in Europe: where do we stand?. Expert Review of Vaccines 13:8, pages 979-987.
Read now
Anja Takla, Merle M Böhmer, Christina Klinc, Norbert Kurz, Alice Schaffer, Heribert Stich, Petra Stöcker, Ole Wichmann & Judith Koch. (2014) Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011. Human Vaccines & Immunotherapeutics 10:1, pages 140-145.
Read now

Articles from other publishers (29)

Steven A. Rubin. 2023. Plotkin's Vaccines. Plotkin's Vaccines 711 736.e10 .
Carlo Di Pietrantonj, Alessandro Rivetti, Pasquale Marchione, Maria Grazia Debalini & Vittorio Demicheli. (2021) Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database of Systematic Reviews 2021:11.
Crossref
N. V. Turaeva, R. A. Frolov, O. V. Tsvirkun & A. G. Gerasimova. (2021) Characteristics of the epidemiological situation of mumps in the world atthe present stage. Epidemiology and Vaccinal Prevention 20:2, pages 74-82.
Crossref
Nada Madi, Haya Altawalah, Wadha Alfouzan, Widad Al‐Nakib, Ebtehal Al‐Roumi & Ahlam Jeragh. (2020) Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy. Journal of Medical Virology 92:8, pages 963-970.
Crossref
Carlo Di Pietrantonj, Alessandro Rivetti, Pasquale Marchione, Maria Grazia Debalini & Vittorio Demicheli. (2020) Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database of Systematic Reviews.
Crossref
Darren W Westphal, Ashley Eastwood, Avram Levy, Jane Davies, Clare Huppatz, Marisa Gilles, Heather Lyttle, Stephanie A Williams & Gary K Dowse. (2019) A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study. The Lancet Infectious Diseases 19:2, pages 177-184.
Crossref
Mona Marin, Tricia L Kitzmann, Lisa James, Patricia Quinlisk, Wade K Aldous, John Zhang, Cristina V Cardemil, Chris Galeazzi, Manisha Patel & Ismael R Ortega-Sanchez. (2018) Cost of Public Health Response and Outbreak Control With a Third Dose of Measles-Mumps-Rubella Vaccine During a University Mumps Outbreak—Iowa, 2015–2016. Open Forum Infectious Diseases 5:10.
Crossref
Steven A. Rubin. 2018. Plotkin's Vaccines. Plotkin's Vaccines 663 688.e11 .
Stephanie Franz, Paul Rennert, Maria Woznik, Josephine Grützke, Amy Lüdde, Eva Maria Arriero Pais, Tim Finsterbusch, Henriette Geyer, Annette Mankertz & Nicole Friedrich. (2017) Mumps Virus SH Protein Inhibits NF-κB Activation by Interacting with Tumor Necrosis Factor Receptor 1, Interleukin-1 Receptor 1, and Toll-Like Receptor 3 Complexes. Journal of Virology 91:18.
Crossref
Shuk Yi Annie Hui, Daljit S. Sahota & Terence T. Lao. (2017) Impact of the two-dose rubella vaccination regimen on incidence of rubella seronegativity in gravidae aged 25 years and younger. PLOS ONE 12:8, pages e0183630.
Crossref
Elina Seppälä, Viktor Zöldi, Sakari Vuorinen, Satu Murtopuro, Ulpu Elonsalo, Janko van Beek, Anu Haveri, Mia Kontio, Carita Savolainen-Kopra, Taneli Puumalainen & Jussi Sane. (2017) A cluster of measles linked to an imported case, Finland, 2017. Eurosurveillance 22:33.
Crossref
Kimberly M. Thompson, Cassie L. Odahowski, James L. Goodson, Susan E. Reef & Robert T. Perry. (2016) Synthesis of Evidence to Characterize National Measles and Rubella Exposure and Immunization Histories. Risk Analysis 36:7, pages 1427-1458.
Crossref
Mia Kontio, Arto A. Palmu, Ritva K. Syrjänen, Mika Lahdenkari, Esa Ruokokoski, Irja Davidkin, Outi Vaarala & Merit Melin. (2016) Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months. Journal of Infectious Diseases 213:12, pages 2005-2013.
Crossref
Maiju M. Saarinen, Matti Sillanpää, Dieter Schmidt & Lauri J. Virta. (2016) Long-term changes in the incidence of childhood epilepsy. A population study from Finland. Epilepsy & Behavior 58, pages 81-85.
Crossref
Sanjay Lalwani, Sukanta Chatterjee, Sundaram Balasubramanian, Ashish Bavdekar, Shailesh Mehta, Sanjoy Datta, Michael Povey & Ouzama Henry. (2015) Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial. BMJ Open 5:9, pages e007202.
Crossref
E. Leuridan, K. Maertens, M. Wautier, V. Hutse & H. Theeten. (2015) Susceptibility to measles, mumps, and rubella in 5-year-old children in Flanders, Belgium. European Journal of Pediatrics 174:7, pages 925-932.
Crossref
S. Petersen, H.F. Rabenau, A. Mankertz, D. Matysiak-Klose, I. Friedrichs & Sabine Wicker. (2014) Immunität gegen Masern beim medizinischen Personal des Universitätsklinikums Frankfurt, 2003–2013Immunity against measles among healthcare personnel at the University Hospital Frankfurt, 2003–2013. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 58:2, pages 182-189.
Crossref
A. E. Barskey, P. Juieng, B. L. Whitaker, D. D. Erdman, M. S. Oberste, S.-W. W. Chern, D. S. Schmid, K. W. Radford, R. J. McNall, P. A. Rota, C. J. Hickman, W. J. Bellini & G. S. Wallace. (2013) Viruses Detected Among Sporadic Cases of Parotitis, United States, 2009-2011. Journal of Infectious Diseases 208:12, pages 1979-1986.
Crossref
O. Wichmann & B. Ultsch. (2013) Effektivität, Populationseffekte und Gesundheitsökonomie der Impfungen gegen Masern und RötelnEffectiveness, population-level effects, and heath economics of measles and rubella vaccination. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 56:9, pages 1260-1269.
Crossref
J. Koch & A. Takla. (2013) Effekte der Masern-Mumps-Röteln (MMR)-Impfung auf die Epidemiologie von Mumps in DeutschlandEffects of the MMR vaccination on the epidemiology of mumps in Germany. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 56:9, pages 1305-1312.
Crossref
S. Waaijenborg, S. J. M. Hahne, L. Mollema, G. P. Smits, G. A. M. Berbers, F. R. M. van der Klis, H. E. de Melker & J. Wallinga. (2013) Waning of Maternal Antibodies Against Measles, Mumps, Rubella, and Varicella in Communities With Contrasting Vaccination Coverage. Journal of Infectious Diseases 208:1, pages 10-16.
Crossref
J. ERIKSEN, I. DAVIDKIN, G. KAFATOS, N. ANDREWS, C. BARBARA, D. COHEN, A. DUKS, A. GRISKEVICIUS, K. JOHANSEN, K. BARTHA, B. KRIZ, G. MITIS, J. MOSSONG, A. NARDONE, D. O'FLANAGAN, F. DE ORY, A. PISTOL, H. THEETEN, K. PROSENC, M. SLACIKOVA & R. PEBODY. (2012) Seroepidemiology of mumps in Europe (1996–2008): why do outbreaks occur in highly vaccinated populations?. Epidemiology and Infection 141:3, pages 651-666.
Crossref
Steven A. Rubin & Stanley A. Plotkin. 2013. Vaccines. Vaccines 419 446 .
Albert E. Barskey, Cynthia Schulte, Jennifer B. Rosen, Elizabeth F. Handschur, Elizabeth Rausch-Phung, Margaret K. Doll, Kisha P. Cummings, E. Oscar Alleyne, Patricia High, Jacqueline Lawler, Andria Apostolou, Debra Blog, Christopher M. Zimmerman, Barbara Montana, Rafael Harpaz, Carole J. Hickman, Paul A. Rota, Jennifer S. Rota, William J. Bellini & Kathleen M. Gallagher. (2012) Mumps Outbreak in Orthodox Jewish Communities in the United States. New England Journal of Medicine 367:18, pages 1704-1713.
Crossref
Anu Kantele, Leena Mattila, Kristi Ott, Irja Davidkin & Heli Siikamäki. (2012) Fever With Rash in Patients Returning From Popular Tourist Resort Phuket, Thailand: Dengue—or Measles?: Table 1. Journal of Travel Medicine 19:5, pages 317-319.
Crossref
Hubert Nielly, Clotilde Bauer, Fabien Ramon, Fabrice Castel & Benoît Houzé. (2012) Limites d'application des recommandations de prise en charge de cas groupés de rougeole en milieu professionnel. Santé Publique Vol. 24:2, pages 157-163.
Crossref
U. Heininger, N.S. Bachtiar, P. Bahri, A. Dana, A. Dodoo, J. Gidudu & E. Matos dos Santos. (2012) The concept of vaccination failure. Vaccine 30:7, pages 1265-1268.
Crossref
Keita Matsubara, Satoshi Iwata & Tetsuo Nakayama. (2012) Antibodies against mumps virus component proteins. Journal of Infection and Chemotherapy 18:4, pages 466-471.
Crossref
Annette Mankertz, Mick N. Mulders, Sergey Shulga, Jacques R. Kremer, Kevin E. Brown, Sabine Santibanez, Claude P. Muller, Nina Tikhonova, Galina Lipskaya, Dragan Jankovic, Nino Khetsuriani, Rebecca Martin & Eugene Gavrilin. (2011) Molecular Genotyping and Epidemiology of Measles Virus Transmission in the World Health Organization European Region, 2007–2009. The Journal of Infectious Diseases 204:suppl_1, pages S335-S342.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.